Somatrogon-ghla

Orphan Drug Cold Chain RequiredFDA Approved

Description

Somatrogon-ghla is a recombinant human growth hormone indicated for pediatric patients. It is used for the treatment of growth hormone deficiency.

Indications & Therapeutic Use

Growth hormone deficiency

Linked Diseases:

Global Availability (2 countries)

CountryAccess RouteRegulatory PathwayLead TimeStatus

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
Somatrogon-ghla
Generic NameSomatrogon-ghla
Brands1 brand available
Active IngredientSomatrogon-ghla
Drug ClassGrowth hormone deficiency
ManufacturerPfizer
Dosage FormsInjection
Medical CodeH01AC07
Orphan StatusYes — Orphan Drug
Cold ChainRequired
Reg. StatusFDA Approved
Clinical TrialNCT02963098
Countries2 countries
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes